Table 3 Primer sequences used in this study

From: Inhibition of FOXC2 restores epithelial phenotype and drug sensitivity in prostate cancer cells with stem-cell properties

Target (F/R)

Primer sequence (5′ to 3′)

AR-F

5'-GACGCTTCTACCAGCTCACC -3′

AR-R

5′-GCTTCACTGGGTGTGGAAAT -3′

Bmi1-F

5′- CCAGGGCTTTTCAAAAATGA-3′

Bmi1-R

5′- CCGATCCAATCTGTTCTGGT-3′

CDH1-F

5′-TGCCCAGAAAATGAAAAAGG -3′

CDH1-R

5′-GTGTATGTGGCAATGCGTTC -3′

CDH2-F

5′-GACAATGCCCCTCAAGTGTT -3′

CDH2-R

5′-CCATTAAGCCGAGTGATGGT -3′

Col3A1-F

5′-GGGAACAACTTGATGGTGCT -3′

Col3A1-R

5′- CCTCCTTCAACAGCTTCCTG-3′

FN1-F

5′-CAGTGGGAGACCTCGAGAAG -3′

FN1-R

5′-GTCCCTCGGAACATCAGAAA -3′

FOXC2-F

5′- AGAATTACTACCGGGCTGCG-3′

FOXC2-R

5′-TGAGCGCGATGTAGCTGTAG -3′

HPRT-F

5′-TGCTCGAGATGTGATGAAGG -3′

HPRT-R

5′-TCCCCTGTTGACTGGTCATT -3′

PSA-F

5′- AGTGCGAGAAGCATTCCCAA-3′

PSA-R

5′- GAAGCTGTGGCTGACCTGAA-3′

Slug-F

5′- GAGCATTTGCAGACAGGTCA-3′

Slug-R

5′-GCTTCGGAGTGAAGAAATGC -3′

Snai1-F

5′-ACCCCACATCCTTCTCACTG -3′

Snai1-R

5′-TACAAAAACCCACGCAGACA -3′

Twist1-F

5′-GGAGTCCGCAGTCTTACGAG -3′

Twist1-R

5′-CCAGCTTGAGGGTCTGAATC -3′

Vimentin-F

5′-GAGAACTTTGCCGTTGAAGC -3′

Vimentin-R

5′- TCCAGCAGCTTCCTGTAGGT-3′

Zeb1-F

5′- GCACAACCAAGTGCAGAAGA-3′

Zeb1-R

5′-CATTTGCAGATTGAGGCTGA -3′

CHGA-F

5′-TGAAATGCATCGTTGAGGTC-3′

CHGA-R

5′-ACCGCTGTGTTTCTTCTGCT-3′

SYP-F

5′-TAGGACCCAAGGTGGTCTTG-3′

SYP-R

5′-TACTCTGGAGCCCACCATTC-3′

CD56-F

5′-CGGCATTTACAAGTGTGTGG-3′

CD56-R

5′-GACATCTCGGCCTTTGTGTT-3′

NSE-F

5′-GTCCCACGTGTCTTCCACTT-3′

NSE-R

5′-CCCAAGTCAGGCCAGTTTTA-3′

Back to article page